Synopsys (SNPS) Tops Q3 EPS by 24c; offers guidance

Synopsys (NASDAQ: SNPS) reported Q3 EPS of $3.91, $0.24 better than the analyst estimate of $3.67. Revenue for the quarter came in at $2.48 billion versus the consensus estimate of $2.44 billion.

GUIDANCE:

Synopsys sees Q4 2026 EPS of $4.10-$4.16, versus the consensus of $3.99. Synopsys sees Q4 2026 revenue of $2.53-2.58 billion, versus the consensus of $2.552 billion.

Synopsys sees FY2026 EPS of $15.04-$15.10, versus the consensus of $14.77. Synopsys sees FY2026 revenue of $9.69-9.74 billion, versus the consensus of $9.677 billion.

For earnings history and earnings-related data on Synopsys (SNPS) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• Lantronix (LTRX) Reports In-Line Q4 EPS; Offers Guidance
• Synopsys shares fall despite earnings beat and raised 2026 outlook